Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Reality Aniseikonia and Metamorphopsia Testing

NCT: NCT07838181 · RECRUITING

NCT IDNCT07838181
StatusRECRUITING
Start Date2026-08-04
Completion2030-06-30
SponsorNYU Langone Health (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess whether the use of small, lightweight, portable virtual reality headset devices can provide a more accessible, reliable, contained, and convenient testing environment compared to previous platforms. Many tests only assess distortions in one plane or meridian and may have confounding effects from factors such as external stimuli or the use of colored filters to selectively display images to each eye. The investigators hypothesize that this device will help minimize, if not get rid of, a lot of these confounding factors that exist currently.

Frequently Asked Questions

What is Virtual Reality Aniseikonia and Metamorphopsia Testing?

Virtual Reality Aniseikonia and Metamorphopsia Testing is a clinical trial registered under NCT07838181. Current status: RECRUITING.

What is the status of NCT07838181?

The current status of NCT07838181 (Virtual Reality Aniseikonia and Metamorphopsia Testing) is: RECRUITING.

When did Virtual Reality Aniseikonia and Metamorphopsia Testing start?

Virtual Reality Aniseikonia and Metamorphopsia Testing started on 2026-08-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑